Cadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell Carcinoma
Status:
Not yet recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
This is a single-arm, multicenter, exploratory study to evaluate the efficacy and safety of
AK104 in combination with cisplatin and paclitaxel in the treatment of resectable locally
advanced esophageal squamous carcinoma.